Content
All Posts > Content under Pharma/Biotech
Korea Stock: Sinil Pharmaceutical
Article By:
Andrew Stotz
Read
Wednesday, August 5, 2020 6:54 AM EDT
Sinil Pharmaceutical Company Limited manufactures pharmaceutical products. It operates through the following business divisions: Drugs, Health Functional Food, Cosmetics, Real Estate, and Quasi-Drugs.
Cannabis Central: Another Day, Another 2.7% Gain
Article By:
Lorimer Wilson
Read
Wednesday, August 5, 2020 4:10 AM EDT
The Pot Stock Index of the 25 pure-play cannabis stocks that consistently trade above US$1/share matched Monday's 2.7% gain. 14 of the constituents went up, 2 had No Change in price and 2 of the 3 associated sector categories also went up.
Market Briefing For Wednesday, August 5
Article By:
Gene Inger
Read
Wednesday, August 5, 2020 2:12 AM EDT
The pandemic is not over. There is also an epidemic of violence by those who do not grasp the importance of both freedom of expression, free-market capitalism, and what some allege is now 'insurrection' requiring Federal intervention.
Incyte Q2 Earnings And Revenues Beat Estimates
Article By:
Zacks Investment Research
Read
Tuesday, August 4, 2020 9:55 AM EDT
Incyte came out with quarterly earnings of $1.24 per share.
In this article: INCY
Cannabis Central: Check Out Australia's 16 Cannabis Companies & How To Buy Them
Article By:
Lorimer Wilson
Read
Tuesday, August 4, 2020 7:46 AM EDT
It is forecasted that the Oceania region will be worth A$1.55B by 2024 with 79% of that being comprised within Australia, so an Australian Cannabis Index has been created to track the performance of the 16 cannabis companies operating in the country.
Cannabis Central: These 8 Pot Stocks Have Gone Down 40% To 60% YTD
Article By:
Lorimer Wilson
Read
Tuesday, August 4, 2020 4:19 AM EDT
Of the 300 cannabis stocks that actively trade on the various Canadian and American stock exchanges only 25 are pure-play cannabis companies who derive 100% of their revenue from the sale of cannabis or cannabis-related products.
Market Briefing For Tuesday, August 4
Article By:
Gene Inger
Read
Tuesday, August 4, 2020 2:26 AM EDT
Stimulus bill delays didn't inhibit the Senior Indexes retaining their gains; while for sure it inhibits millions of Americans who will cease lots of consumer spending as the indirect subsidies are forestalled.
CytoDyn’s Data: Approvable Drug Sets Stage For Near-Term Move Upward
Article By:
Moon Kil Woong
Read
Monday, August 3, 2020 8:00 PM EDT
Cytodyn, is set to move on positive information and this article gives updated information on why it may move in the near term and an update on their Covid drug trial.
Speculative Rally In Biotech Today, Is The Correction Over Already?
Article By:
Rod Raynovich
Read
Monday, August 3, 2020 7:01 PM EDT
The economy and the market wants solutions to the pandemic and biotech seems to have breaking news on therapies and vaccines for traders daily.
Money Monday
Article By:
Vivian Lewis
Read
Monday, August 3, 2020 6:25 PM EDT
Today, after the pileup of results last week, markets caught their breath and rose. We had good news from a Japanese favorite, bad news from a British bank we sold, and good news for a Chinese firm.The Dow is up too.
Street Missing 'Eye-Catching' CymaBay Data, Says Piper Sandler
Article By:
The Fly
Read
Monday, August 3, 2020 1:36 PM EDT
August 3's topline data from CymaBay's halted Phase 3 study answered key questions for seladelpar around its effect on itch, a hallmark symptom of primary biliary cholangitis, Piper Sandler analyst Yasmeen Rahimi tells investors in a research note.
In this article: CBAY
